✦ LIBER ✦

T.P.1 02 A phase I/II clinical trial in Duchenne muscular dystrophy using IM and IV delivered antisense oligonucleotides: The MDEX consortium

✍ Scribed by V. Arechavala; K. Bushby; G. Dickson; I. Graham; M. Kinali; K. Liu; J. Morgan; F. Muntoni; L. Popplewell; T. Partridge; F. Thorogood; K. Wells; N. Wells; M. Wood; H. Yin

Book ID: 116792594
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 46 KB
Volume: 16
Category: Article
ISSN: 0960-8966
DOI: 10.1016/j.nmd.2006.05.138

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

149th ENMC International Workshop and 1s

149th ENMC International Workshop and 1st TREAT-NMD Workshop on: “Planning Phase I/II Clinical trials using Systemically Delivered Antisense Oligonucleotides in Duchenne Muscular Dystrophy”

✍ Francesco Muntoni; Kate D. Bushby; Gertjan van Ommen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 117 KB

128th ENMC International Workshop on ‘Pr

128th ENMC International Workshop on ‘Preclinical optimization and Phase I/II Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy’ 22–24 October 2004, Naarden, The Netherlands

✍ Francesco Muntoni; Kate Bushby; Gertjan van Ommen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 118 KB